FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:HALO

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) witnessed volume of 2.48 million shares during last trade however it holds an average trading capacity of 612,021.00 shares. HALO last trade opened at $7.92 reached intraday low of $7.72 and went +6.48% up to close at $8.22.

Enzo Biochem (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT recently announced further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

ADVERTISE WITH US